Probo Medical, a global provider of diagnostic imaging solutions, has announced key leadership changes, with Michael Asmer transitioning from CEO to Chairman of the Board and Greg Kopulos appointed as the company's new Chief Executive Officer. Greg Kopulos will be leading Probo Medical from its Tampa Florida offices, marking a new chapter for the company.
Before founding MedCorp, which was acquired by Probo Medical in 2018, Michael Asmer held leadership roles at Physician Sales and Service (PSS) and Henry Schein. PSS was later acquired by McKesson.
Greg Kopulos brings extensive leadership experience from his time as President of Clinical Quality Solutions at Chartis, a healthcare consulting firm, and his 20-year career at GE Healthcare, where he held roles such as Chief Operating Officer of Global Service and Senior Vice President of Strategy. He holds an MBA from Marquette University and a Bachelor's degree from the University of Wisconsin-Whitewater.
Probo Medical is backed by Avista Healthcare Partners, a leading private equity firm with a strong focus on healthcare. With over $8 billion invested in more than 45 healthcare companies worldwide, Avista’s support has been pivotal in Probo's strategic growth.
"Probo is well on its way to becoming a global leader in diagnostic imaging solutions. I am humbled and excited to build on the great work of Michael and the entire Probo team," remarked Kopulos. "With the continued investment in and integration of our prior acquisitions, Probo has never been better positioned to help our customers deliver quality care to their patients while providing needed cost savings."
Probo Medical is a global diagnostic imaging solutions provider to the medical and veterinary industry. We specialise in offer sales, service, rental and repair and can offer an extensive inventory of new and refurbished systems ranging from Ultrasound to MRI.
